Gamification and Social Incentives for Peripheral Arterial Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Peripheral Arterial Disease+1 More
Gamification and Social Incentives - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare a Fitbit-based walking program with a gamified interface to a standard walking program in patients with intermittent claudication.

Eligible Conditions
  • Peripheral Arterial Disease
  • Peripheral Arterial Disease (PAD)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Peripheral Arterial Disease

Study Objectives

0 Primary · 1 Secondary · Reporting Duration: 24 Weeks

24 Weeks
Change in PROMIS mobility, pain interference, and satisfaction with social roles and activities scores
Change in SF-36 physical functioning scale
Change in Walking Impairment Questionnaire score
Change in daily number of minutes engaged in light, moderate, or vigorous physical activity
Change in daily step count

Trial Safety

Safety Progress

1 of 3

Other trials for Peripheral Arterial Disease

Trial Design

2 Treatment Groups

Control
1 of 2
Intervention
1 of 2
Active Control
Experimental Treatment

100 Total Participants · 2 Treatment Groups

Primary Treatment: Gamification and Social Incentives · No Placebo Group · N/A

Intervention
Behavioral
Experimental Group · 1 Intervention: Gamification and Social Incentives · Intervention Types: Behavioral
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 24 weeks

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
1,816 Previous Clinical Trials
41,114,993 Total Patients Enrolled
4 Trials studying Peripheral Arterial Disease
1,275 Patients Enrolled for Peripheral Arterial Disease
Alexander Fanaraff, MD, MHSPrincipal InvestigatorUniversity of Pennsylvania
Alexander Fanaroff, MD, MHSPrincipal InvestigatorUniversity of Pennsylvania
4 Previous Clinical Trials
2,418 Total Patients Enrolled
1 Trials studying Peripheral Arterial Disease
1,200 Patients Enrolled for Peripheral Arterial Disease

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
The text says that you have to be at least 18 years old to drink.
Uses a smartphone or tablet that operates on either the iOS or Android operating system.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 3rd, 2021

Last Reviewed: October 2nd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.